Crescentis Capital Ltd

Crescentis Capital Board Meeting Date

Crescentis Capital will hold a board meeting on September 29, 2026, to discuss progress on its proposed rights issue of equity shares.

Crescentis Capital Annual General Meeting

Crescentis Capital Limited conducted its 33rd Annual General Meeting on August 26, 2026. The meeting transacted key business, including director reappointments and ESOP plan approvals.

Crescentis Capital Q1 FY27 Results: Net Profit ₹7.8 Cr, Up 129.4% YoY

Crescentis Capital Ltd reported revenue from operations of ₹10.9 Cr (+118.0% YoY) and net profit of ₹7.8 Cr (+129.4% YoY) for Q1 FY27.

Key figure

Net profit ₹7.8 Cr · +129.4% YoY

Crescentis Capital Board Meeting Date

Crescentis Capital Limited will hold a board meeting on 13th August, 2026, to consider and approve the unaudited financial results for the quarter ended 30th June, 2026.

Crescentis Capital Annual General Meeting

Crescentis Capital Limited scheduled its 33rd Annual General Meeting for August 26, 2026. The meeting will address financial statements and the re-appointment of directors.

Crescentis Capital Other Announcement

Crescentis Capital Limited submitted its Reconciliation of Share Capital Audit Report for the quarter ended June 30, 2026. This filing confirms compliance with SEBI Regulation 76.

Crescentis Capital Management Change

Mr. Sai Kumar Subramanya resigned as Head – Business Development (AVP) of Crescentis Capital Limited. The resignation is effective from July 16, 2026.

Crescentis Capital Business Update

Crescentis Capital Ltd filed its quarterly shareholding pattern as of 30 June 2026, detailing holdings across promoters, public and institutions. No financial or capital changes were disclosed.

Crescentis Capital Promoter Buying (Off-Market)

Dr. Bhaskara Rao Bollineni gifted 3,00,000 shares to Mr. Bhavanam Ruthvik Reddy. This inter-se transfer represents 1.76% of the company's paid-up equity capital.

Crescentis Capital Results Correction

Crescentis Capital Limited submitted a corrected declaration regarding its unmodified audit opinion for FY26 results. The filing fixes a previous clerical error in regulatory reporting.

Crescentis Capital Management Change

Crescentis Capital re-appointed Mr. Subba Rao Meka as MD and Mr. Bhavanam Reddy as CEO for five-year terms. These leadership continuities support long-term strategic execution.

Execution

5 Years

Crescentis Capital Employee Stock Options

Crescentis Capital Limited granted 5,00,000 stock options to its Managing Director at Rs. 50 each. Totaling ₹2.50 Crore, the options vest over two years.

Value

₹2.50 Cr

Execution

3 years from vesting

Crescentis Capital Other Announcement

Crescentis Capital Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report indicates no material non-compliance or deviations.

Crescentis Capital Q4 FY26 Results: Net Loss of ₹7.4 Cr, Loss Widens

Crescentis Capital Ltd reported revenue from operations of -₹7.4 Cr and a net loss of ₹7.4 Cr for Q4 FY26.

Key figure

Net loss ₹7.4 Cr

Crescentis Capital Financial Results

Crescentis Capital approved audited FY26 financial results and a ₹80 Crore rights issue. The fundraise aims to strengthen the company's capital base.

Value

₹80.00 Cr

Crescentis Capital Board Meeting Date

Crescentis Capital Limited scheduled a board meeting for May 29, 2026, to approve annual financial results and explore fund-raising options. Trading window remains closed.

Crescentis Capital Patent

Crescentis Capital Limited rebranded its corporate identity and filed trademark applications for its new logo. This follows its formal name change effective January 2026.

Crescentis Capital Adverse Business Impact

Crescentis Capital reported temporary website downtime due to third-party server issues. Operations remain secure and functional while restoration efforts are currently underway.

Crescentis Capital Other Announcement

Crescentis Capital Limited (formerly Som Datt Finance Corporation Limited) confirmed it does not meet the criteria for identification as a 'Large Corporate' for FY 2026-27. This regulatory filing complies with SEBI's operational circular regarding debt raising norms.

Execution

Financial Year 2026-27

Crescentis Capital Employee Stock Options

Crescentis Capital Ltd has received in-principle approval from BSE for the issuance of up to 13,00,000 equity shares. These shares will be allotted upon the exercise of options under the 'Employees' Stock Option Scheme 2025'. This regulatory milestone facilitates the company's long-term employee incentive and retention plans.

Som Datt Finance Corporation Q3 FY26 Results: Turns Profitable, Net Profit ₹1.2 Cr

Som Datt Finance Corporation Ltd reported net profit of ₹1.2 Cr for Q3 FY26.

Key figure

Net profit ₹1.2 Cr